• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性附件可能来源于沃尔夫管的肿瘤是否为良性病变?对英文文献的系统回顾。

Is female adnexal tumour of probable wolffian origin a benign lesion? A systematic review of the English literature.

机构信息

Department of Histopathology, St. James' University Hospital, Leeds, West Yorkshire, United Kingdom.

出版信息

Pathology. 2009;41(7):645-8. doi: 10.3109/00313020903273084.

DOI:10.3109/00313020903273084
PMID:20001344
Abstract

AIMS

To establish the prognosis associated with female adnexal tumour of probable wolffian origin (FATWO) and determine the frequency with which it behaves as a truly benign lesion.

METHODS

Medline and Embase electronic databases were interrogated to identify 31 papers describing 63 patients with FATWO with follow up.

RESULTS

Fifty (79%, CI 67.4-87.3%) were alive and well but seven patients had recurrent or residual disease (11.1%, CI 5.6-21.5%) and three had died of disease (4.8%, CI 1.6-13.1%). Stage (p = 0.0002) and differentiation (p = 0.0118) showed a significant association with outcome although atypia approached significance at the 5% level (p = 0.0658). One patient with a ruptured tumour had recurrent disease and one other had died of disease (p = 0.2278). There was no association between outcome and age (p = 0.6651), size (p = 0.1912), length of survival (p = 0.2351) tumour site, mitotic rate or necrosis (p = 0.5937, 0.4697 and 0.2016, respectively).

CONCLUSION

On the basis of these findings, FATWO cannot be regarded as a benign lesion. These lesions may be confused with well differentiated gynaecological cancers and careful clinicopathological correlation with the extensive use of immunohistochemistry is encouraged to ensure that lesions such as extragonadal endometrioid adenocarcinoma is not confused with FATWO.

摘要

目的

确定女性附件可能来源于 Wolffian 组织的肿瘤(FATWO)的预后,并确定其表现为真正良性病变的频率。

方法

通过 Medline 和 Embase 电子数据库检索了 31 篇描述了 63 例具有 FATWO 并随访的患者的论文。

结果

50 例(79%,CI 67.4-87.3%)存活且情况良好,但 7 例患者有复发或残留疾病(11.1%,CI 5.6-21.5%),3 例患者死于疾病(4.8%,CI 1.6-13.1%)。分期(p=0.0002)和分化(p=0.0118)与预后显著相关,尽管不典型性在 5%水平接近显著(p=0.0658)。1 例破裂肿瘤患者有复发疾病,另 1 例患者死于疾病(p=0.2278)。预后与年龄(p=0.6651)、大小(p=0.1912)、生存时间(p=0.2351)、肿瘤部位、有丝分裂率或坏死(p=0.5937、0.4697 和 0.2016)无关。

结论

根据这些发现,FATWO 不能被视为良性病变。这些病变可能与分化良好的妇科癌症混淆,鼓励仔细的临床病理相关性,并广泛使用免疫组织化学,以确保不会将诸如卵巢外子宫内膜样腺癌与 FATWO 混淆。

相似文献

1
Is female adnexal tumour of probable wolffian origin a benign lesion? A systematic review of the English literature.女性附件可能来源于沃尔夫管的肿瘤是否为良性病变?对英文文献的系统回顾。
Pathology. 2009;41(7):645-8. doi: 10.3109/00313020903273084.
2
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
3
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.
4
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.紫杉烷类单药治疗方案用于复发性上皮性卵巢癌。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3.
5
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
7
Treatment options for progression or recurrence of glioblastoma: a network meta-analysis.治疗胶质母细胞瘤进展或复发的选择:网络荟萃分析。
Cochrane Database Syst Rev. 2021 May 4;5(1):CD013579. doi: 10.1002/14651858.CD013579.pub2.
8
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
9
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
10
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.

引用本文的文献

1
Malignant Wolffian adnexal tumor in the ovary: a case report and literature review.卵巢恶性中肾旁管附属器肿瘤:1例报告及文献复习
Front Oncol. 2025 Mar 18;15:1526030. doi: 10.3389/fonc.2025.1526030. eCollection 2025.
2
Case report: Report of a case of female adnexal malignant tumor of Wolffian origin.病例报告:1例源自中肾管的女性附件恶性肿瘤病例报告。
Front Oncol. 2024 Sep 16;14:1458817. doi: 10.3389/fonc.2024.1458817. eCollection 2024.
3
Rare giant female adnexal tumor of probable Wolffian origin: a case report.罕见的可能起源于沃尔夫管的巨大女性附件肿瘤:病例报告
J Surg Case Rep. 2022 May 27;2022(5):rjac243. doi: 10.1093/jscr/rjac243. eCollection 2022 May.
4
RARE MALIGNANT FEMALE ADNEXAL TUMOR OF WOLFFIAN ORIGIN (FATWO) WITH MULTIPLE RELAPSES AND CHEMOTHERAPY REGIMENS.罕见的起源于沃尔夫管的女性附件恶性肿瘤(FATWO)伴多次复发及化疗方案
Acta Endocrinol (Buchar). 2021 Apr-Jun;17(2):259-265. doi: 10.4183/aeb.2021.259.
5
MRI, CT and FDG-PET/CT findings of Wolffian tumor: four-case series.MRI、CT 和 FDG-PET/CT 检查在 Wolffian 肿瘤中的表现:四例病例系列。
Jpn J Radiol. 2021 Oct;39(10):1009-1016. doi: 10.1007/s11604-021-01145-1. Epub 2021 Jun 5.
6
Malignant Female Adnexal Tumor of Probable Wolffian Origin (FATWO): A case report and review for the literature.可能起源于沃尔夫管的恶性女性附件肿瘤(FATWO):一例病例报告及文献复习
Gynecol Oncol Rep. 2021 Feb 9;36:100726. doi: 10.1016/j.gore.2021.100726. eCollection 2021 May.
7
Female adnexal tumour of probable Wolffian origin: a rare entity with challenging histopathological diagnosis and unpredictable behaviour.可能起源于沃尔夫管的女性附件肿瘤:一种组织病理学诊断具有挑战性且行为不可预测的罕见实体。
BMJ Case Rep. 2020 Oct 4;13(10):e237127. doi: 10.1136/bcr-2020-237127.
8
Female adnexal tumor of probable Wolffian Origin - A report of two cases at one institution.可能起源于沃尔夫管的女性附件肿瘤——一家机构的两例报告。
Gynecol Oncol Rep. 2020 Jul 21;33:100612. doi: 10.1016/j.gore.2020.100612. eCollection 2020 Aug.
9
Wolffian tumor (female adnexal tumor of Wolffian origin) presenting as a pelvic side wall mass: Report of a case.表现为盆腔侧壁肿块的中肾管瘤(源自中肾管的女性附件肿瘤):病例报告
SAGE Open Med Case Rep. 2019 Apr 1;7:2050313X19839534. doi: 10.1177/2050313X19839534. eCollection 2019.
10
Female Adnexal Tumour of Probable Wolffian Origin (FATWO): Review of the Literature.可能起源于沃尔夫管的女性附件肿瘤(FATWO):文献综述
Geburtshilfe Frauenheilkd. 2019 Mar;79(3):281-285. doi: 10.1055/a-0746-8985. Epub 2019 Mar 12.